Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.53
-0.16 (-2.81%)
At close: Mar 5, 2026, 4:00 PM EST
5.56
+0.03 (0.54%)
After-hours: Mar 5, 2026, 4:41 PM EST
Compass Therapeutics Employees
Compass Therapeutics had 35 employees as of December 31, 2024. The number of employees increased by 3 or 9.38% compared to the previous year.
Employees
35
Change (1Y)
3
Growth (1Y)
9.38%
Revenue / Employee
n/a
Profits / Employee
-$1,899,686
Market Cap
983.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35 | 3 | 9.38% |
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Valneva SE | 700 |
| Maravai LifeSciences Holdings | 550 |
| Xeris Biopharma Holdings | 394 |
| UroGen Pharma | 287 |
| Sana Biotechnology | 194 |
| Inhibrx Biosciences | 161 |
| Cullinan Therapeutics | 111 |
CMPX News
- 9 hours ago - Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Compass Therapeutics: Exciting Clinical Updates Inbound For 2026 - Seeking Alpha
- 7 weeks ago - Compass Therapeutics, Inc. (CMPX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Compass Therapeutics Provides Corporate Update - GlobeNewsWire
- 2 months ago - Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Compass Therapeutics Announces Key Leadership Appointments - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 3 months ago - Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha